Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02125084
Title Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists Fort Myers Florida 33916 United States Details
Florida Cancer Center Saint Petersburg Florida 33705 United States Details
Oncology Hematology Care Inc. Cincinnati Ohio 45242 United States Details
Tennessee Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field